Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06293651
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-15
Brief Title:
Clinical Trial to Investigate Safety Tolerability Pharmacokinetics Pharmacodynamics and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Dong-A ST Co Ltd
Organization:
Dong-A ST Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-15
First Submit QC Date:
February 27 2024
Study First Post Date:
2024-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL